Oral oxymetholone reduces mortality induced by gamma irradiation in mice through stimulation of hematopoietic cells

Molecular and Cellular Biochemistry

Volumn 287, Issue 1-2, 2006, Pages 193-199

  Hosseinimehr, Seyed Jalal ^a   Zakaryaee, Valiallah ^b   Froughizadeh, Mohsen ^b  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Novin Medical Radiation Institute   (Iran)

Author keywords

Hematopoietic; Oxymetholone; Radiation; Radioprotective; Survival

Indexed keywords

OXYMETHOLONE;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEEDING; GAMMA IRRADIATION; HEMATOPOIETIC CELL; IONIZING RADIATION; LEUKOCYTE COUNT; LEUKOPENIA; MALE; MORTALITY; MOUSE; MYELOPOIESIS; NONHUMAN; OPTIMAL DRUG DOSE; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PROTECTION; SURVIVAL RATE; THROMBOCYTOPENIA; WHOLE BODY RADIATION;

ANIMALS; BLOOD CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG EVALUATION, PRECLINICAL; GAMMA RAYS; HEMATOPOIETIC SYSTEM; MICE; MYELOPOIESIS; OXYMETHOLONE; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; SURVIVAL RATE; THROMBOCYTOPENIA;

ANIMALIA;

EID: 33745945058     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-9111-5     Document Type: Article

References (24)

1. Whitnall MH, Elliott TB, Harding RA, Inal CE, Landauer MR, Wilhelmsen CL, MacKinney L, Miner VL, Jackson WE, Loria RM, Ledney GD, Seed TM: Androstendiol stimulates myelopoiesis and enhances resistance to infection in gamma-irradiated mice. Inter J Immunopharm 22: 1-14, 2000
2. Nunia V, Goyal PK: Prevention of gamma radiation induced anemia in mice by diltiazem. J Radiat Res 45: 11-17, 2004
3. Drouet M, Mourcin F, Grenier N, Leroux V, Denis J, Mayol JF, Thullier P, Lataillade JJ, Herodin F: Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppresion: Long-term follow-up. Blood 103: 878-885, 2004
4. Farese AM, Hunt P, Grab LB, MacVittie TJ: Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J Clin Invest 97: 2145-2151, 1996
5. Hosseinimehr SJ, Shafiee A, Mozdarani H, Akhlagpour S: Radioprotective effects of 2-iminothiazolidine derivatives against lethal dose of gamma radiation in mice. J Radiat Res 42: 401-408, 2001
6. Hosseinimehr SJ, Shafiee A, Mozdarani H, Akhlagpour S, Froughizadeh M: Radioprotective effects of 2-imino -3 (chromone-2-yl) carbonyl thiazolidine against gamma irradiation in mice. J Radiat Res 43:293-300, 2002
7. Jagetia GC, Baliga MS, Venkatesh P, Ulloor JN: Influence of ginger rhizome (Zingiber officinalis Rosc) on survival, glutathione and lipid peroxidation in mice after whole-body exposure to gamma radiation. Radiat Res 160: 584-592, 2003
8. Landauer MR, Castro CA, Benson KA, Hogan JB, Weiss JF: Radioprotective and locomotor responses of mice treated with nimodipine alone and in combination with WR-151327. J Appl Toxicol 21: 25-31, 2001
9. Pavlatos AM, FultzAO, Monberg MJ, Vootkur A: Review of oxymetholone: a 17α-alkylated anabolic-androgenic steroid. Clin Ther 23: 789-801,2001
10. Hengge UR, Stocks K, Wiehler H, Faulkner S, Esser S, Lorenz C, Jentzen W, Hengge D, Goos M, Dudley RE, Ringham G: Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting. AIDS 28: 699-710, 2003
11. Bolton S: StatistEcal inference: estimation and hypothesis testing In: Pharmaceutical Statistics Practical and Clinical Applications 3th Edition,Eds. J. Swarbrick, Inc, Marcel Dekker, New York, pp.162-178, 1997
12. Mauch P, Constine L, Greenberger J, Knospe W, Sullivan W, Liesveld JL, Deeg HJ: Hematopoietic stem celA compartment: acute and late effects of radiation therapy and chemotherapy. Int J Radiat Biol Oncol Biol Phys 31:1319-1339, 1995
13. Dainiak N: Hematological consequences of exposure to ionizing radiation. Exp Hematol 30: 513-528, 2002
14. Herodin F, Bourin P, Mayol JF, Lataillade JJ, Drouet M: Short-term injection of antiapoptotic cytokine combinations soon after lethal γ-irradiation promotes survival. Blood 101: 2609-2616, 2003
15. Lord B., Hendry,BJH: Radiation toxicology: bone marrow and leukemia. In: Radiation toxicology: Bone marrow and leukemia. (J. H. Lord, Eds), Taylor & Francis, London, pp. 1-21, 1995
16. Patchen ML: Single and combination cytokine therapies for the treatment of radiation-induced hematopoietic injury. Adv Biosci 94: 21-36, 1996
17. Neta R: Modulation of radiation damage by cytokines. Stem Cells Dayt 15:87-94, 1997
18. Whitnall MH, Wilhelmsen CL, Mckinney L, Miner V, Seed TM, Jackson WE: Radioprotective efficacy and acute toxicity of 5-androstenediol after subcutaneous or oral administration in mice. Immunopharm Immunotoxicol 24:595-626, 2002
19. Song JY, Han SK, Bae KG, Lim DS, Son SJ, Jung IS, Yi SY, Yun YS: Radioprotective effects of Ginsan, an immunomodulator. Radiat Res 159:768-774, 2003
20. Shahidi NT: A review of the chemistry, biological, action, and clinical applications of anabolic-androgenic steroids. Clin Ther 23:1355-1384, 2001
21. Shahidi NT: Androgen and erythropoiesis. N Engl J Med 289: 72-80, 1973
22. Kim SW, Hwang JH, Cheon JM, Park NS, Park SE, Park SJ, Yun HJ, Kim S, Jo DY. Direct and indirect effects of androgens on survival of hematopoietic progenitor cells in vitro. J Korean Med Sci 20: 409-416, 2005
23. Pamujula S, Graves RA, Freeman T, Srinivasan V, Bostanian LA, Kishore V, Mandal TK: Oral delivery of spray dried PLGA/amifostine nanoparticles. J Parm Pharmacol 56: 1119-1125, 2004
24. National Toxicology Program.: NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser 485: 1-233, 1995